HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

arogya-wardhani

combination of Shuddha mercury, sulfur, iron, mica, copper, plant extracts for viral hepatitis in India

Also Known As:

arogyavardhini; Arogya-wardhani

Networked: 7 relevant articles (1 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Pharmaceutical Preparations
- Drug Combinations: 5337
  - arogya-wardhani: 7
- Plant Extracts: 3916
  - arogya-wardhani: 7
Inorganic Chemicals: 9
- Metals: 20694
  - arogya-wardhani: 7
Complex Mixtures: 1906
- Biological Products
  - Plant Preparations: 622
    - Plant Extracts: 3916
      - arogya-wardhani: 7

Experts

1.	Gupta, Yogendra Kumar: 2 articles (07/2013 - 04/2012)
2.	Kumar, Gajendra: 2 articles (07/2013 - 04/2012)
3.	Sharma, Surinder Kumar: 2 articles (07/2013 - 04/2012)
4.	Srivastava, Amita: 2 articles (07/2013 - 04/2012)
5.	Dave, Alankruta R: 1 article (07/2019)
6.	Goyal, Mandip: 1 article (07/2019)
7.	Padhar, Bharatkumar Chhaganbhai: 1 article (07/2019)

Related Diseases

1.	Dyslipidemias (Dyslipidemia) 04/01/2012 - "In conclusion, the results of the present prospective cohort study showed that Ayurvedic treatment (Arjuna powder and Arogyavardhini Vati) is safe and effective for dyslipidemia." 04/01/2012 - "Therefore, the objective of this study was to evaluate the safety and efficacy of Ayurvedic treatment (Arjuna powder and Arogyavardhini Vati) for dyslipidemia patients. " 04/01/2012 - "Safety and efficacy evaluation of Ayurvedic treatment (Arjuna powder and Arogyavardhini Vati) in dyslipidemia patients: A pilot prospective cohort clinical study."
2.	Hepatitis 10/01/1980 - "A double-blind clinical trial of Arogya-wardhani--an ayurvedic drug--in acute viral hepatitis." 07/01/1978 - "A pilot phase II trial with arogya-wardhani and Punarnavadi-Kwath in viral hepatitis." 01/01/1987 - "'Arogyavardhini'-an indigenous formulation was evaluated for its hepatoprotective activity in rats, using two models of carbon tetrachloride (CCl4) hepatic damage, one simulating vital hepatitis and the other simulating fatty change. " 05/01/1994 - "Effects of single doses of kumari asav, kumari kalp, arogyavardhini and tamra bhasma on lysosomal enzymes (acid phosphatase and beta-glucuronidase) of rat liver and kidney were studied during hepatitis induced by single 0.3 ml/kg body wt dose of CCl4. "
3.	Hyperlipidemias (Hyperlipidemia) 07/01/2013 - "Therefore, present study was designed to evaluate the effect of Arogyavardhini vati in Triton WR-1339-induced hyperlipidemia in rats. " 07/01/2013 - "for 7 days after inducing hyperlipidemia) and Arogyavardhini vati treated (50, 100, 200 mg/kg, p.o. " 07/01/2013 - "Anti-hyperlipidemic activity evaluation of Arogyavardhini vati against Triton WR-1339-induced hyperlipidemia in rats. "
4.	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/01/2019 - "Clinical study of Arogyavardhini compound and lifestyle modification in management of metabolic syndrome: A double‑blind placebo controlled randomized clinical trial."
5.	Hypercholesterolemia 07/01/2013 - "Arogyavardhini vati, a traditionally used Ayurvedic medicine may be a useful therapy for hypercholesterolemia through reducing oxidative stress (decreasing MDA and increasing GSH) and lipid levels."

Related Drugs and Biologics

1.	Powders
2.	Punarnavadi-kwath
3.	Lipids
4.	Glucuronidase
5.	Enzymes
6.	Carbon Tetrachloride (Tetrachloromethane)
7.	Acid Phosphatase

Related Therapies and Procedures

1.	Therapeutics
2.	Ayurvedic Medicine (Siddha Medicine)